Imricor Medical Systems, Inc.
IMR.AX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$466.14M
Close$
$-0.06
104.7% downside
Current Fair Value
104.7% downsideOvervalued by 104.7% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $466.14 Million |
|---|---|
| Enterprise Value | $439.63 Million |
| Earnings per Share | $-0.09 |
| Beta | 0.48 |
| Outstanding Shares | 314,234,650 |
Return
| Return on Equity | -230.31% |
|---|---|
| Return on Assets | -90.97% |
| Return on Invested Capital | -125.52% |
Valuation & Multiples
| P/E Ratio | -7.98 |
|---|---|
| PEG | -2.83 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 569.51 |
| Enterprise Value to EBIT | -10.61 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 1.17 |
Revenue Sources
No data
Next Earnings Call
Expected Date
December 2, 2026
EPS Estimate
$-0.03
Consensus analyst estimateRevenue Estimate
$143,984
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Imricor Medical Systems, Inc.
78 employees
CEO: Steven Wedan
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Mi...